A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

CBSE allows students with Type 1 diabetes to carry insulin pumps and glucometers, highlighting the need for paediatric ...

Howard Look announced that he is stepping down from his role as CEO at automated insulin delivery technology developer Tidepool.

Inhaled insulin, known as Afrezza, provides a needle-free option for managing Type 1 diabetes. The treatment is currently ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

CGM approved by FDA for adults with diabetes; U.S. launch set for late 2025 with extended wear and advanced tracking features ...

At the recent ATTD 2025 meeting, participants discussed recent progress and remaining challenges in developing a fully closed ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

Recent decades have seen a lot of progress in diabetes treatment. In a new study, Per-Ola Carlsson, Professor of Medical Cell Biology, has obtained promising results. "This is the first time anyone ...

Learn about the 4 essential types of diabetes, their unique characteristics, risk factors, and management strategies to ...